Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The purpose of this study was to investigate the correlation between the level of mutated mitochondrial DNA in muscle and oxidative capacity in 24 patients with mitochondrial myopathy (MM). Maximal oxygen uptake (VO 2max), workload (W max), and venous plasma lactate levels were measured during an incremental cycle test to exhaustion in 17 patients with point mutations of mtDNA and in seven with single, large‐scale deletions of mtDNA (chronic progressive external ophthalmoplegia [CPEO]). Results were compared with those in 25 healthy matched subjects. The mutation load in MM patients was 67 ± 5% (range, 29 – 99%). VO 2max and W max correlated with percentage of heteroplasmy (r > 0.82; p < 0.005) and were lower in patients versus healthy subjects (p < 0.000005). Exercise‐induced peak increases in heart rate, ventilation, and resting plasma lactate levels correlated with muscle mutation load (r > 0.71; p < 0.005). Exercise‐induced increases in plasma lactate correlated with muscle mutation load in CPEO patients (r = 0.95; p < 0.005). Impaired oxidative capacity and ragged red muscle fibers were found in CPEO and 3243A→G patients with mutation loads as low as 45 and 57%, respectively. The study indicates that oxidative capacity correlates directly with skeletal muscle mutation load in MM patients, and that the mutation threshold level for impaired oxidative metabolism in MM patients is lower than found in in vitro studies. Ann Neurol 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA
Andrews, R. M., Kubacka, I., Chinnery, P. F., Lightowlers, R. N., Turnbull, D. M., & Howell, N. (1999) · Nature Genetics · doi:10.1038/13779 · Cited by 3,337 · cited 1×
“The obtained sequences were compared with the revised Cambridge reference sequence (AC J01415).(19,20) The 3243A3G mutation was tested by restriction analysis using the enzyme ApaI.”
MethodGoto, Y.-I., Nonaka, I., & Horai, S. (1990) · Nature · doi:10.1038/348651a0 · Cited by 2,070
The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients
Taivassalo, T. (2003) · Brain · doi:10.1093/brain/awg028 · Cited by 282
Cited by
Balady, G. J., Arena, R., Sietsema, K., Myers, J., Coke, L., Fletcher, G. F., Forman, D., Franklin, B., Guazzi, M., Gulati, M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181e52e69 · Cited by 1,964
Guazzi, M., Adams, V., Conraads, V., Halle, M., Mezzani, A., Vanhees, L., Arena, R., Fletcher, G. F., Forman, D. E., Kitzman, D. W., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31826fb946 · Cited by 822
“7 Under current medical management strategies, a VE / V CO 2 slope ≥ 45 and a peak V O 2 , 10.0 mL O 2 † kg 2 1 † min 2 1 are indicative of a particularly poor prognosis over the 4-year period following CPX. 34 Other CPX variables have emerged in recent years that appear to further refine prognostic resolution.”
InfluentialWriting Committee, EACPR:, Guazzi, M., Adams, V., Conraads, V., Halle, M., Mezzani, A., Vanhees, L., AHA:, Arena, R., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs221 · Cited by 318
Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
Jeppesen, T. D., Schwartz, M., Olsen, D. B., Wibrand, F., Krag, T., Duno, M., Hauerslev, S., & Vissing, J. (2006) · Brain · doi:10.1093/brain/awl149 · Cited by 211
“VO2max and plasma lactate and CK: Determination of VO2max and peak exercise-induced plasma lactate levels was carried out as described previously (Jeppesen et al., 2003).”
BackgroundMethod
Metadata
- Authors
- Jeppesen, T. D., Schwartz, M., Olsen, D. B., & Vissing, J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2003-06-25
- Volume
- 54
- Issue
- 1
- Pages
- 86-92
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2042547152
- Cited by
- 75
- References
- 3
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.